Cyclic Peptide projects

PUREfrex® RD generates various cyclic peptides for many targets.

A paper on CTLA-4-binding cyclic peptides and their peptidomimetic small molecules by joint research by GeneFrontier and PRISM BioLab has been published in Pharmaceuticals.

 

No. Target Stage
No.1 CTLA-4 (inhibitor) Lead optimization
No.2 Her2 Lead optimization
No.3 EGFR Lead optimization
No.4 Erk2 Lead optimization
No.5 IL-6 (inhibitor) Lead optimization
No.6 TNF-α Under screening
No.7 Herceptin Hit identification for Mimotope

 

 

 

Related Products and Services

PUREfrex RD
PUREfrex® RD
Drug Discovery
Drug Discovery